VistaGen Therapeutics Inc...

NASDAQ: VTGN · Real-Time Price · USD
3.31
0.35 (12.01%)
At close: Aug 15, 2025, 3:59 PM
3.30
-0.30%
After-hours: Aug 15, 2025, 06:22 PM EDT

VistaGen Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
-51.42M -29.36M -59.25M -47.76M -17.93M
Depreciation & Amortization
635K 568K 509.8K 711.1K 117.6K
Stock-Based Compensation
4.32M 2.18M 3.34M 3.48M 2.31M
Other Working Capital
-921K 271K 2.96M -1.69B 3.48M
Other Non-Cash Items
-389K 6K -929.14M 232K 2.53M
Deferred Income Tax
n/a n/a 932.8M n/a -2.53M
Change in Working Capital
4.76M 793K 2.03M -1.92M 3.44M
Operating Cash Flow
-42.1M -25.81M -49.72M -45.26M -12.07M
Capital Expenditures
-191K -61K -212K -200.4K -275.4K
Cash Acquisitions
n/a n/a -528.3K n/a n/a
Purchase of Investments
-24.98M n/a n/a n/a n/a
Sales Maturities Of Investments
12.03M n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a
Investing Cash Flow
-13.15M -61K -740.3K -200.4K -275.4K
Debt Repayment
n/a -985K -1.04M -3K -382K
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a -945.1M -1.39B
Other Financial Acitivies
201K 8K n/a 951.15M 1.39B
Financial Cash Flow
3.21M 128.4M -1.04M 10.48M 114.1M
Net Cash Flow
-52.03M 102.53M -51.5M -34.97M 101.75M
Free Cash Flow
-42.29M -25.87M -49.93M -45.46M -12.35M